Metabolic and pharmacological characteristics of the bicyclic nucleoside analogues (BCNAs) as highly selective inhibitors of varicella-zoster virus (VZV). 2003

R Sienaert, and L Naesens, and A Brancale, and A Carangio, and G Andrei, and R Snoeck, and A Van Kuilenburg, and E De Clercq, and C McGuigan, and J Balzarini
Rega Institute for Medical Research, K.U. Leuven, Leuven, Belgium.

UI MeSH Term Description Entries
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D006574 Heterocyclic Compounds, 2-Ring A class of heterocyclic compounds that include a two-ring fused structure. Both aromatic and non-aromatic ring structures are included in this category. Fused Heterocyclic Compounds, Two-Ring,Two Ring Heterocyclic Compounds,2-Ring Heterocyclic Compounds,Fused Heterocyclic Compounds, Two Ring,Heterocyclic Compounds, 2 Ring
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001643 Bridged Bicyclo Compounds Saturated alicyclic hydrocarbon molecules consisting of two rings that have two non-adjacent atoms in common. Bicyclo Compounds,Bicyclo Compounds, Bridged
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014645 Herpesvirus 3, Human The type species of VARICELLOVIRUS causing CHICKENPOX (varicella) and HERPES ZOSTER (shingles) in humans. Chickenpox Virus,Herpes zoster Virus,Ocular Herpes zoster Virus,VZ Virus,Varicella-Zoster Virus,HHV-3,Herpesvirus 3 (alpha), Human,Herpesvirus Varicellae,Human Herpesvirus 3,Chickenpox Viruses,Herpes zoster Viruses,VZ Viruses,Varicella Zoster Virus,Varicella-Zoster Viruses,Varicellae, Herpesvirus
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D018258 Herpesvirus 2, Human A species of SIMPLEXVIRUS associated with genital infections (HERPES GENITALIS). It is transmitted by sexual intercourse and close personal contact. HSV-2,Herpes Simplex Virus 2,Human Herpesvirus 2,HHV-2,Herpes Simplex Virus Type 2,Herpesvirus 2 (alpha), Human

Related Publications

R Sienaert, and L Naesens, and A Brancale, and A Carangio, and G Andrei, and R Snoeck, and A Van Kuilenburg, and E De Clercq, and C McGuigan, and J Balzarini
July 2002, The Journal of antimicrobial chemotherapy,
R Sienaert, and L Naesens, and A Brancale, and A Carangio, and G Andrei, and R Snoeck, and A Van Kuilenburg, and E De Clercq, and C McGuigan, and J Balzarini
November 1999, Journal of medicinal chemistry,
R Sienaert, and L Naesens, and A Brancale, and A Carangio, and G Andrei, and R Snoeck, and A Van Kuilenburg, and E De Clercq, and C McGuigan, and J Balzarini
January 2001, Nucleosides, nucleotides & nucleic acids,
R Sienaert, and L Naesens, and A Brancale, and A Carangio, and G Andrei, and R Snoeck, and A Van Kuilenburg, and E De Clercq, and C McGuigan, and J Balzarini
February 2001, Bioorganic & medicinal chemistry letters,
R Sienaert, and L Naesens, and A Brancale, and A Carangio, and G Andrei, and R Snoeck, and A Van Kuilenburg, and E De Clercq, and C McGuigan, and J Balzarini
May 2003, Medicinal research reviews,
R Sienaert, and L Naesens, and A Brancale, and A Carangio, and G Andrei, and R Snoeck, and A Van Kuilenburg, and E De Clercq, and C McGuigan, and J Balzarini
June 2000, Bioorganic & medicinal chemistry letters,
R Sienaert, and L Naesens, and A Brancale, and A Carangio, and G Andrei, and R Snoeck, and A Van Kuilenburg, and E De Clercq, and C McGuigan, and J Balzarini
May 2001, Antiviral chemistry & chemotherapy,
R Sienaert, and L Naesens, and A Brancale, and A Carangio, and G Andrei, and R Snoeck, and A Van Kuilenburg, and E De Clercq, and C McGuigan, and J Balzarini
November 2009, Bioorganic & medicinal chemistry letters,
R Sienaert, and L Naesens, and A Brancale, and A Carangio, and G Andrei, and R Snoeck, and A Van Kuilenburg, and E De Clercq, and C McGuigan, and J Balzarini
April 2009, Bioorganic & medicinal chemistry,
R Sienaert, and L Naesens, and A Brancale, and A Carangio, and G Andrei, and R Snoeck, and A Van Kuilenburg, and E De Clercq, and C McGuigan, and J Balzarini
January 2003, Nucleosides, nucleotides & nucleic acids,
Copied contents to your clipboard!